Retatrutide

Retatrutide is a triple GIP/GLP-1/GCG receptor agonist developed for advanced metabolic research applications. It combines the mechanisms of multiple incretin pathways, potentially offering enhanced effects on weight reduction and glycemic control. This compound represents the next generation in polypharmacological metabolic research.